FDA Reversals on UniQure, Moderna Approvals Worry Investors
Investors are concerned about the fate of multiple experimental drugs for difficult-to-treat diseases following a series of recent rejections by…
Spdr S&P Biotech Etf
FDA Official Discusses UniQure Gene Therapy for Huntington's Disease
Thomas Fuller | SOPA Images | Light rocket | fake images UniQure needs to conduct another study to show that…
Novo Nordisk Shares Fall as Weight Loss Drug Fails to Beat Eli Lilly
The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, November 5, 2025. Nichlas Pollier | Bloomberg | fake images…
FDA agrees to review Moderna's flu vaccine application after denial
A researcher works in the laboratory at Moderna's headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg…
FDA chief warns that US is losing ground to China in early drug trials
Food and Drug Administration Commissioner Marty Makary warned that the United States is falling behind China in the early stages…
The best selections of Biotechnology and Farma by JPMorgan for the second half
The low performance of biopharmaceutical actions versus the widest market for a third consecutive year is an opportunity for investors,…
Vaccine stocks fall after Peter Marks of the FDA renounces RFK Jr.
Rafael Henrique | LIGHTROCKET | Getty images The actions of the main vaccine manufacturers fell on Monday after a key…
Innovative biotech stocks have a good chance of breaking out in 2025
The trends may be turning in favor of biotech stocks in 2025 after several years of poor performance, but it…
Jim Cramer on Eli Lilly (LLY) after Trump picks RFK Jr. to lead HHS
Enthusiasm for Eli Lilly, the club's holding company, needs to be tempered, at least for now, as Wall Street grapples…